Yifan Pharmaceutical Co., Ltd. (SHE: 002019)
China
· Delayed Price · Currency is CNY 13.49
+0.84 (6.64%)
Oct 8, 2024, 3:04 PM CST
Yifan Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 7, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 14,609 | 18,014 | 15,019 | 21,745 | 23,372 | 17,082 | Upgrade
|
| Market Cap Growth | -15.51% | 19.94% | -30.93% | -6.96% | 36.83% | 32.27% | Upgrade
|
| Enterprise Value | 15,885 | 19,400 | 16,499 | 22,717 | 23,710 | 17,640 | Upgrade
|
| Last Close Price | 12.01 | 14.64 | 12.13 | 17.45 | 18.70 | 15.97 | Upgrade
|
| PE Ratio | - | -32.53 | 80.89 | 75.88 | 23.67 | 21.59 | Upgrade
|
| PS Ratio | 3.09 | 4.43 | 3.91 | 4.93 | 4.33 | 3.29 | Upgrade
|
| PB Ratio | 1.72 | 2.18 | 1.64 | 2.48 | 2.68 | 2.18 | Upgrade
|
| P/FCF Ratio | -90.73 | -115.84 | -213.92 | -80.39 | 59.50 | 240.02 | Upgrade
|
| P/OCF Ratio | 44.36 | 51.68 | 31.82 | 72.19 | 21.08 | 18.23 | Upgrade
|
| EV/Sales Ratio | 3.34 | 4.77 | 4.30 | 5.15 | 4.39 | 3.40 | Upgrade
|
| EV/EBITDA Ratio | 34.87 | 72.38 | 43.52 | 50.06 | 19.91 | 14.47 | Upgrade
|
| EV/EBIT Ratio | 107.50 | 926.80 | 96.29 | 86.48 | 23.38 | 16.56 | Upgrade
|
| EV/FCF Ratio | -95.86 | -124.76 | -234.99 | -83.98 | 60.36 | 247.87 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.24 | 0.24 | 0.26 | 0.19 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 4.86 | 6.97 | 5.44 | 4.84 | 1.39 | 1.57 | Upgrade
|
| Debt / FCF Ratio | -13.36 | -12.83 | -31.00 | -8.41 | 4.23 | 26.87 | Upgrade
|
| Asset Turnover | 0.38 | 0.34 | 0.31 | 0.37 | 0.48 | 0.50 | Upgrade
|
| Inventory Turnover | 2.47 | 2.43 | 2.65 | 4.16 | 4.91 | 5.22 | Upgrade
|
| Quick Ratio | 0.89 | 0.94 | 1.19 | 1.13 | 1.22 | 0.93 | Upgrade
|
| Current Ratio | 1.38 | 1.49 | 1.68 | 1.56 | 1.65 | 1.22 | Upgrade
|
| Return on Equity (ROE) | -8.55% | -10.18% | 1.42% | 2.77% | 11.25% | 11.87% | Upgrade
|
| Return on Assets (ROA) | 0.75% | 0.11% | 0.87% | 1.38% | 5.58% | 6.39% | Upgrade
|
| Return on Capital (ROIC) | 0.84% | 0.12% | 0.96% | 1.53% | 6.30% | 7.37% | Upgrade
|
| Earnings Yield | -2.77% | -3.06% | 1.27% | 1.28% | 4.14% | 5.29% | Upgrade
|
| FCF Yield | -1.13% | -0.86% | -0.47% | -1.24% | 1.68% | 0.42% | Upgrade
|
| Dividend Yield | 1.59% | - | - | - | 0.27% | 0.63% | Upgrade
|
| Payout Ratio | 0.00% | - | 45.18% | 49.71% | 20.86% | 21.29% | Upgrade
|
| Buyback Yield / Dilution | 2.94% | 3.94% | -5.32% | 1.25% | -0.40% | -0.99% | Upgrade
|
| Total Shareholder Return | 4.53% | 3.94% | -5.32% | 1.25% | -0.13% | -0.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.